Physician profile
Michael R Cupp
NPI 1003820150
$5,486.50
in general payments reported to CMS, 2019-2025
44 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $308 · 2021: $906 · 2022: $801 · 2023: $1,151 · 2024: $296 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,148 · Travel and Lodging: $419 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.80 |
| Travel and Lodging | $419.32 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,331.03 | 2021-2025 | Interstim |
| Janssen Biotech, INC. | $651.11 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $454.52 | 2019-2023 | Veozah, Xtandi |
| Pfizer INC. | $332.71 | 2019-2025 | |
| Boston Scientific Corporation | $242.75 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Solyx Sis System |
| Convatec INC. | $184.03 | 2022-2023 | |
| Dendreon Pharmaceuticals LLC | $173.61 | 2019-2023 | Provenge |
| Novartis Pharmaceuticals Corporation | $145.93 | 2019-2025 | |
| Procept Biorobotics Corporation | $130.81 | 2023 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $125.99 | 2021-2023 | Prolaris |
| Rochester Medical Corporation | $123.93 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $111.12 | 2023 | Pylarify |
| Myovant Sciences INC. | $93.36 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $92.14 | 2019-2022 | |
| Abbvie INC. | $89.80 | 2019-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $87.77 | 2023-2024 | Urgent PC Neuromodulation System |
| Calyxo, INC. | $84.90 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $76.57 | 2019-2023 | |
| Travere Therapeutics, INC. | $74.43 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.44 | 2019-2022 | |
| Agiliti Health, INC. | $66.89 | 2025 | Sonablate Hifu, Olympus Soltive Tfl Laser, Quanta System Fiber Dust Tfl Laser |
| Alnylam Pharmaceuticals INC. | $66.72 | 2021-2022 | |
| Accord Healthcare, INC. | $64.25 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $58.80 | 2024-2025 | Adstiladrin |
| Antares Pharma, INC. | $57.51 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $44.86 | 2023 | Yonsa |
| Merck Sharp & Dohme LLC | $43.61 | 2019-2025 | Lynparza |
| Urogen Pharma, INC. | $37.03 | 2023-2024 | Jelmyto |
| Olympus America INC. | $35.22 | 2025 | Itind System |
| Baxter Healthcare | $35.11 | 2023 | Tisseel |
| Amgen INC. | $34.02 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $31.70 | 2020 | |
| Sumitomo Pharma America, INC. | $28.92 | 2024 | Gemtesa |
| Immunitybio, INC. | $28.25 | 2025 | |
| Allergan, INC. | $25.54 | 2021-2022 | |
| Axonics, INC. | $24.32 | 2020 | |
| Genzyme Corporation | $22.16 | 2023 | |
| Telix Pharmaceuticals | $18.45 | 2023 | Illuccix |
| Neotract INC. | $18.20 | 2019 | |
| Tolmar, INC. | $15.75 | 2023 | |
| Hollister Incorporated | $14.68 | 2021 | |
| Zyla Life Sciences, INC. | $14.00 | 2020 | |
| Urovant Sciences INC | $11.71 | 2022 | |
| Clarus Therapeutics INC. | $10.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.